🔎 Trials Near Me

Utama › Glomerulonefritis IgA › California

Kajian klinikal Glomerulonefritis IgA di California

8 kajian untuk Glomerulonefritis IgA sedang mencari peserta di lokasi di California.

Bandar di California

Teks kajian rasmi (Bahasa Inggeris)

A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN)

  • Kidney & Hypertension Center - Apple Valley, Apple Valley
  • Scripps Green Hospital, Carlsbad
  • UCLA Health David Geffen School of Medicine, Los Angeles
  • dan 2 lagi
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT06935357

A Study of JADE101 in Participants With Immunoglobulin A Nephropathy

  • Jade Clinical Site, Chula Vista
Mengambil pesertaFasa 2
Umur 18 hingga 60 · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07541287

Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Iptacopan in Pediatric Patients With Primary IgAN

  • Valley Childrens Hospital, Madera
Mengambil pesertaFasa 3
Umur 2 hingga 18 · Semua jantina · Dikemas kini 9 Sep 2026 · NCT06994845

Study of WAL0921 in Patients With Glomerular Kidney Diseases

  • Academic Medical Research Institute, Los Angeles
Mengambil pesertaFasa 2
Umur 18 hingga 75 · Semua jantina · Dikemas kini 3 Ogo 2026 · NCT06466135

Study of Ravulizumab in Pediatric Participants With Primary IgAN

  • Research Site, Palo Alto
Mengambil pesertaFasa 3
Umur 2 hingga 18 · Semua jantina · Dikemas kini 30 Jul 2026 · NCT07024563

Study to Evaluate the Impact of Iptacopan on Top of SOC on Biopsy Changes in Kidneys of Adult Patients With IgAN

  • UCLA Medical Center, Los Angeles
Mengambil pesertaFasa 2
Umur 18 hingga 99 · Semua jantina · Dikemas kini 29 Jul 2026 · NCT06797518

Atacicept in Multiple Glomerular Diseases

  • Vera Therapeutics, Brisbane
Mengambil pesertaFasa 2
Umur 2 ke atas · Semua jantina · Dikemas kini 26 Jun 2026 · NCT06983028

Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases

  • Cedars-Sinai Medical Center, Los Angeles
Mengambil pesertaFasa 2
Umur 1 hingga 17 · Semua jantina · Dikemas kini 12 Mei 2026 · NCT05003986

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.